Shunji Nishimura

912 total citations
54 papers, 681 citations indexed

About

Shunji Nishimura is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Shunji Nishimura has authored 54 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 20 papers in Rheumatology and 17 papers in Oncology. Recurrent topics in Shunji Nishimura's work include Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Musculoskeletal synovial abnormalities and treatments (8 papers). Shunji Nishimura is often cited by papers focused on Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (12 papers) and Musculoskeletal synovial abnormalities and treatments (8 papers). Shunji Nishimura collaborates with scholars based in Japan, United States and Israel. Shunji Nishimura's co-authors include Masao Akagi, Kazuhiko Hashimoto, Chiaki Hamanishi, Shigeshi Mori, Akio Nishimura, Taiyo Asano, Yasuhiro Okada, Tomohiko Ito, Tatsuya Sawamura and Hiroshi Munakata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Shunji Nishimura

48 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunji Nishimura Japan 13 239 155 120 104 103 54 681
Bo Ci United States 12 107 0.4× 349 2.3× 157 1.3× 66 0.6× 170 1.7× 18 820
Saula Ravasi Italy 13 114 0.5× 210 1.4× 90 0.8× 125 1.2× 44 0.4× 16 583
Liu Yang China 15 69 0.3× 237 1.5× 41 0.3× 75 0.7× 60 0.6× 53 660
Clive Long United Kingdom 11 82 0.3× 193 1.2× 53 0.4× 76 0.7× 45 0.4× 17 598
Yasuhisa Oida Japan 20 178 0.7× 432 2.8× 133 1.1× 85 0.8× 396 3.8× 58 1.1k
Seon‐Hwan Kim South Korea 17 243 1.0× 316 2.0× 105 0.9× 48 0.5× 49 0.5× 69 948
Lingxin Zhang United States 14 99 0.4× 85 0.5× 47 0.4× 62 0.6× 89 0.9× 35 459
Antje Augstein Germany 21 68 0.3× 426 2.7× 94 0.8× 90 0.9× 75 0.7× 45 817
Aimilia Varela Greece 16 131 0.5× 483 3.1× 62 0.5× 79 0.8× 127 1.2× 33 902

Countries citing papers authored by Shunji Nishimura

Since Specialization
Citations

This map shows the geographic impact of Shunji Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunji Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunji Nishimura more than expected).

Fields of papers citing papers by Shunji Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunji Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunji Nishimura. The network helps show where Shunji Nishimura may publish in the future.

Co-authorship network of co-authors of Shunji Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Shunji Nishimura. A scholar is included among the top collaborators of Shunji Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunji Nishimura. Shunji Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Kazuhiko, Shunji Nishimura, & Koji Goto. (2025). PD‑1/PD‑L1 immune checkpoint in bone and soft tissue tumors (Review). Molecular and Clinical Oncology. 22(4). 31–31. 3 indexed citations
2.
Hashimoto, Kazuhiko, Shunji Nishimura, & Koji Goto. (2025). Advanced Metastatic Malignant Triton Tumor in Neurofibromatosis Type 1: A Case Report and Management Challenges. Cancer Diagnosis & Prognosis. 5(3). 410–416.
3.
Hashimoto, Kazuhiko, Shunji Nishimura, & Koji Goto. (2025). Comprehensive Analysis of Osteosarcoma Referral Letters: Insights into Medical Collaboration and Diagnostic Practices at Our Hospital. Cancer Diagnosis & Prognosis. 5(2). 238–243.
4.
Hashimoto, Kazuhiko, Shunji Nishimura, Tomohiko Ito, Ryosuke Kakinoki, & Koji Goto. (2024). Treatment algorithm for metastatic malignancies in the lower extremities. Molecular and Clinical Oncology. 21(1). 51–51.
5.
Hasei, Joe, Ryuichi Nakahara, Yujiro Otsuka, et al.. (2024). The Three-Class Annotation Method Improves the AI Detection of Early-Stage Osteosarcoma on Plain Radiographs: A Novel Approach for Rare Cancer Diagnosis. Cancers. 17(1). 29–29. 2 indexed citations
6.
Hashimoto, Kazuhiko, et al.. (2023). Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors. European Journal of Histochemistry. 67(2). 8 indexed citations
7.
Hashimoto, Kazuhiko, et al.. (2023). Aggressive intraosseous lipoma of the scapula: A case report. Experimental and Therapeutic Medicine. 26(2). 400–400.
8.
Hashimoto, Kazuhiko, et al.. (2023). Involvement of NY-ESO-1 and MAGE-A4 in the pathogenesis of desmoid tumors. Medicine. 102(22). e33908–e33908. 2 indexed citations
9.
Hashimoto, Kazuhiko, Shunji Nishimura, Tomohiko Ito, et al.. (2022). PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report. Medicine. 101(28). e29621–e29621. 2 indexed citations
10.
11.
Hashimoto, Kazuhiko, et al.. (2022). Characterizing inflammatory markers in highly aggressive soft tissue sarcomas. Medicine. 101(39). e30688–e30688. 14 indexed citations
12.
Nakamura, Tomoki, Norifumi Naka, Hiroshi Kobayashi, et al.. (2020). <p>Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group</p>. Cancer Management and Research. Volume 12. 10017–10022. 4 indexed citations
13.
Hashimoto, Kazuhiko, et al.. (2020). Clinical features and outcomes of primary bone and soft tissue sarcomas in adolescents and young adults. Molecular and Clinical Oncology. 12(4). 358–364. 13 indexed citations
14.
Hashimoto, Kazuhiko, et al.. (2020). Outcomes of comprehensive treatment for primary osteosarcoma. SHILAP Revista de lepidopterología. 8. 2107995177–2107995177. 8 indexed citations
15.
Nishimura, Shunji, et al.. (2019). Angiolymphoid hyperplasia with eosinophilia in a hand treated with a reverse digital island flap and artificial skin: a case report. Journal of Medical Case Reports. 13(1). 87–87. 1 indexed citations
16.
Hashimoto, Kazuhiko, et al.. (2018). Clinical outcomes of patients with primary malignant bone and soft tissue tumor aged 65�years or older. Experimental and Therapeutic Medicine. 17(1). 888–894. 9 indexed citations
17.
Hashimoto, Kazuhiko, et al.. (2018). Salmonella Osteomyelitis of the Distal Tibia in a Healthy Woman.. PubMed. 72(6). 601–604. 6 indexed citations
18.
19.
20.
Nishimura, Shunji, et al.. (1992). Post-inhibitory excitation of adenosine on neurotransmission in guinea pig hippocampal slices. Neuroscience Letters. 139(1). 126–129. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Ci Breakdown of academic impact, for papers by Saula Ravasi Breakdown of academic impact, for papers by Liu Yang Breakdown of academic impact, for papers by Clive Long Breakdown of academic impact, for papers by Yasuhisa Oida Breakdown of academic impact, for papers by Seon‐Hwan Kim Breakdown of academic impact, for papers by Lingxin Zhang Breakdown of academic impact, for papers by Antje Augstein Breakdown of academic impact, for papers by Aimilia Varela
Rankless by CCL
2026